Nature Cell started Commercial Clinical Trials Phase Ⅰ and Ⅱ ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer disease treatment in U.S.
SEOUL, South Korea – Bio technology enterprise Nature Cell (KOSDAQ: 007390) announced that it had started to recruit patients for its clinical trials of ‘ASTROSTEM,’ an stem cell drug for Alzheimer disease treatment, in the U.S.
Read more
Most Commented